Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia 5-09-2023, 17:00

Samsung Takes Top Spot in U.S. Patents for Third Year Running while TSMC Rises into Second Place; After Four-Year Falloff, Grants Increase Nearly 4% 14-01-2025, 16:00

Christie’s International Real Estate Enters Vietnam, One of the Fastest-Growing Luxury Markets in the World, via Partnership with S&S Group 20-05-2024, 09:00